159 related articles for article (PubMed ID: 22465234)
1. Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer.
Peng WJ; Zhang JQ; Wang BX; Pan HF; Lu MM; Wang J
Clin Chim Acta; 2012 Jul; 413(13-14):1121-6. PubMed ID: 22465234
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Zhu L; Yu H; Liu SY; Xiao XS; Dong WH; Chen YN; Xu W; Zhu T
PLoS One; 2015; 10(4):e0124230. PubMed ID: 25905787
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.
Liang Y; Guo S; Zhou Q
Tumour Biol; 2014 Apr; 35(4):3717-24. PubMed ID: 24338766
[TBL] [Abstract][Full Text] [Related]
4. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
6. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of the prognostic value of TP53 dependent etoposide-induced gene 24 in non-small cell lung cancer.
Wang M; Li P; Wan R; Liu X
Biomed Pharmacother; 2019 Apr; 112():108590. PubMed ID: 30784913
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis for cyclin E in lung cancer survival.
Huang LN; Wang DS; Chen YQ; Li W; Hu FD; Gong BL; Zhao CL; Jia W
Clin Chim Acta; 2012 Apr; 413(7-8):663-8. PubMed ID: 22244930
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis.
El-Badrawy MK; Yousef AM; Shaalan D; Elsamanoudy AZ
J Bronchology Interv Pulmonol; 2014 Oct; 21(4):327-34. PubMed ID: 25321452
[TBL] [Abstract][Full Text] [Related]
11. The role of cyclin D1 expression and patient's survival in non-small-cell lung cancer: a systematic review with meta-analysis.
Zhang LQ; Jiang F; Xu L; Wang J; Bai JL; Yin R; Wu YQ; Meng LJ
Clin Lung Cancer; 2012 May; 13(3):188-95. PubMed ID: 22133292
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis.
Gong L; Wu D; Zou J; Chen J; Chen L; Chen Y; Ni C; Yuan H
Oncotarget; 2016 Apr; 7(14):18458-68. PubMed ID: 26918342
[TBL] [Abstract][Full Text] [Related]
13. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
14. GOLPH3 overexpression is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through upregulating MMP-2 and MMP-9.
Wang R; Ke ZF; Wang F; Zhang WH; Wang YF; Li SH; Wang LT
Cell Physiol Biochem; 2015; 35(3):969-82. PubMed ID: 25659977
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Tissue Inhibitor of Metalloproteinase-1 in Non- Small Cell Lung Cancer: Systematic Review and Meta-Analysis.
Selvaraj G; Kaliamurthi S; Lin S; Gu K; Wei DQ
Curr Med Chem; 2019; 26(42):7694-7713. PubMed ID: 30182835
[TBL] [Abstract][Full Text] [Related]
16. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer.
Skjefstad K; Grindstad T; Khanehkenari MR; Richardsen E; Donnem T; Kilvaer T; Andersen S; Bremnes RM; Busund LT; Al-Saad S
Steroids; 2016 Sep; 113():5-13. PubMed ID: 27234503
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis.
Li W; Tse LA; Wang F
Steroids; 2015 Dec; 104():129-36. PubMed ID: 26456481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
